Pathologists at South Carolina Hospital Are Preparing to Use Next Generation Gene Sequencing for Cancer Patients

Strategic collaboration promises leap forward in personalized medicine that could be game-changing for medical laboratories One early effort to apply next generation gene sequencing to cancer diagnostics and therapeutics is a collaboration that involves Greenville Hospital System University Medical Center (GHS) in Greenville, South Carolina, and Lab21, Inc., a British company. GHS wants to use next gene sequencing as an integral part of the evaluation of every cancer patient cared for in the...

Pathology Labs Might Benefit from $1 Million Challenge to Sequence the Genome of a Single Cancer Cell

Goal is to produce accurate sequence of one human cancer cell; could lead to new cancer tests Pathologists and clinical laboratory managers will find the latest “prize” for a genetic breakthrough to have direct relevance to molecular diagnostics. One million dollars will go to the first person who sequences an entire cancer cell genome, including all of the RNA, using a specific whole human genome sequencer made by Carlsbad, California-based Life Technologies (NASDAQ: LIFE). This is the fourth...

Is Whole-genome Sequencing Reaching a Tipping Point for Clinical Pathology Laboratories?

High-Density Sequencing Chips Will Soon Be Able To Sequence Five Million SNPs Rapid gene sequencing is catching the interest of progressive anatomic pathologists. These medical laboratory professionals are interested in using rapid gene sequencing technology to allow them to study tens and hundreds of genes on a patient specimen. The technologies used in rapid gene sequencing are being developed and improved by a handful of biotech companies who are racing each other be first to deliver...
;